CAS 1610964-64-1

Unesbulin

CAS: 1610964-64-1

Unesbulin (PTC596) is an orally active and selective inhibitor of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1).

Formula: C₁₉H₁₃F₅N₆

Purezza: 98.71%

Colore e forma: Solid

Peso molecolare: 420.34

Ref: TM-T12575

5-fluoro-2-(6-fluoro-2-methyl-1H-benzimidazol-1-yl)-N⁴-[4-(trifluoromethyl)phenyl]-4,6-pyrimidinediamine

CAS: 1610964-64-1

Formula: C₁₉H₁₃F₅N₆

Purezza: %

Colore e forma: Solid

Peso molecolare: 420.3387

Ref: IN-DA01LIAP

5-Fluoro-2-(6-Fluoro-2-Methyl-1H-Benzo[D]Imidazol-1-Yl)-N4-(4-(Trifluoromethyl)Phenyl)Pyrimidine-4,6-Diamine

CAS: 1610964-64-1

5-Fluoro-2-(6-Fluoro-2-Methyl-1H-Benzo[D]Imidazol-1-Yl)-N4-(4-(Trifluoromethyl)Phenyl)Pyrimidine-4,6-Diamine

Purezza: 98%

Peso molecolare: 420.34g/mol

Ref: 54-PC108595

Unesbulin

CAS: 1610964-64-1

Unesbulin

Purezza: ≥98%

Peso molecolare: 420.34g/mol

Ref: 54-BUP01583

5-Fluoro-2-(6-fluoro-2-methyl-1H-benzo[d]imidazol-1-yl)-N4-(4-(trifluoromethyl)phenyl)pyrimidine-4,6-diamine

CAS: 1610964-64-1

Formula: C₁₉H₁₃F₅N₆

Purezza: 98+%

Peso molecolare: 420.347

Ref: 10-F546699

PTC596

CAS: 1610964-64-1

PTC596 is a histidine-based molecule that has been shown to induce apoptotic cell death in cancer cells, including murine leukemia. PTC596 is undergoing clinical development for the treatment of cancer and other diseases. It has synergistic effects with anticancer drugs and hematopoietic cells, which may be due to its ability to induce mitochondrial membrane potential and angiogenic factors. PTC596 also inhibits the growth of various types of cancer stem cells.

Formula: C₁₉H₁₃F₅N₆

Purezza: Min. 95%

Peso molecolare: 420.3 g/mol

Ref: 3D-KPC96464